查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676623

骨科生物材料市场：全球规模、占有率和趋势分析（2025-2031） - MedSuite

Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more
出版日期: | 出版商: iData Research Inc. | 英文 492 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

到2024年，全球骨科生物材料市场价值预计将达到 73亿美元。预计到2031年市场规模将达到 96亿美元，年复合成长率为 4.0%。

预计2020年全球60岁以上人口将超过10亿，到2050年将达到21亿。这种人口变化预计将推动对骨移植和骨科生物材料的需求增加，特别是对于与年龄相关的骨关节炎和退化性椎间盘疾病特定的脊椎融合手术。

与年龄相关的疾病发生率上升以及肥胖等级上升将推动对骨科生物材料和修復程序的需求。脊椎融合手术的兴起将大大促进骨移植替代品市场的发展。

富含血小板血浆和骨髓抽吸浓缩物等创新疗法再生医学领域不断扩展。新的软骨修復技术改善患者的治疗效果并减少关节置换手术的需求。

本报告概述了全球骨科生物材料市场，包括各细分市场的市场趋势、市场驱动因素和限制因素、竞争市场占有率分析以及参与市场的公司概况。

目录

执行摘要

研究方法

产品评分

  • 简介
  • 产品组合
    • 骨移植替代品
    • 生长因子
    • 细胞疗法
    • 玻尿酸关节内替代疗法（HAV）
    • 软骨修復

    监理问题与召回

    • 骨移植替代品市场 FDA 召回
    • 生长因子市场 FDA 召回

    临床试验

    • 骨移植替代品市场的临床试验
    • 生长因子市场的临床试验
    • 细胞治疗市场的临床试验
    • 玻尿酸关节内替代治疗市场
    • 软骨修復市场的临床试验

全球骨科生物材料市场概况

  • 简介
  • 市场概况与趋势分析
    • 依细分
    • 依地区
  • 驱动因素和限制因素
  • 竞争市场占有率分析
  • 合併和收购
  • 公司简介
    • Arthrex
    • Biocomposites
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Farmaceutici
    • Isto Biologics
    • Harvest Technologies (Terumo)
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • Orthofix
    • Sanofi
    • SeaSpine
    • Stryker
    • Vericel
    • Xtant Medical
    • Zimmer Biomet
  • SWOT 分析

骨科骨移植替代品市场

  • 执行摘要
  • 简介
  • 程式数量
  • 市场概况
  • 市场分析与预测
  • 计数分析
  • 驱动因素和限制因素
  • 竞争市场占有率分析

骨科生长因子市场

  • 执行摘要
  • 简介
  • 程式数量
  • 市场分析与预测
  • 计数分析
  • 驱动因素和限制因素
  • 竞争市场占有率分析

骨科细胞治疗市场

  • 执行摘要
  • 简介
  • 程式数量
  • 市场概况
  • 市场分析与预测
  • 计数分析
  • 驱动因素和限制因素
  • 竞争市场占有率分析

玻尿酸关节内替代疗法市场

  • 执行摘要
  • 简介
  • 程式数量
  • 市场概况
  • 市场分析与预测
  • 驱动因素和限制因素
  • 竞争市场占有率分析

骨科软骨修復市场

  • 执行摘要
  • 简介
  • 程式数量
  • 市场概况
  • 市场分析与预测
  • 驱动因素和限制因素
  • 竞争市场占有率分析

缩写

Product Code: iDATA_GLOB25_MS

The global orthopedic biomaterials device market was valued at $7.3 billion in 2024 and is expected to grow at a CAGR of 4.0%, reaching $9.6 billion by 2031.

This market includes multiple key segments:

  • Bone Graft Substitute Market (Allograft, Demineralized Bone Matrix (DBM), and Synthetic Bone Grafts)
  • Orthopedic Growth Factor Market
  • Orthopedic Cell Therapy Market (Bone Marrow Aspirate Concentrate, Platelet-Rich Plasma)
  • Hyaluronic Acid (HA) Viscosupplementation Market (Single-, Two-, Three-, and Five-Injection Cycles)
  • Orthopedic Cartilage Repair Market (Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, and Osteochondral Autografts)

Market Insights & Data Coverage

  • Unit Sales & Average Selling Prices
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Historical Data (2021-2023)
  • Competitive Landscape, Mergers & Acquisitions
  • Company Profiles & Product Portfolios

Market Trends

Aging Population Driving Market Growth:

  • The global population aged 60+ surpassed 1 billion in 2020 and is projected to reach 2.1 billion by 2050.
  • This demographic shift is expected to increase the demand for bone grafts and orthopedic biomaterials, especially for spinal fusion procedures due to age-related osteoarthritis and degenerative disc disease.

Growing Incidence of Osteoarthritis & Degenerative Conditions:

  • Higher rates of age-related diseases and rising obesity levels will drive demand for orthopedic biomaterials and restorative procedures.
  • Increased spinal fusion procedures will significantly boost the market for bone graft substitutes.

Advancements in Cell Therapy & Cartilage Repair:

  • Innovative therapies like platelet-rich plasma and bone marrow aspirate concentrates are expanding in regenerative medicine.
  • New cartilage repair techniques are improving patient outcomes and reducing the need for total joint replacements.

Market Share Insights

Top Competitors in the Global Orthopedic Biomaterials Market (2024):

1 Medtronic

* Market leader in orthopedic biomaterials, particularly bone graft substitutes and orthopedic growth factors.

* The INFUSE(TM) product line is a dominant player in the orthopedic growth factor market.

2 DePuy Synthes (Johnson & Johnson)

* Second-largest market share, strong presence in bone graft substitutes and HA viscosupplementation.

* Distributes leading HA products MONOVISC(R) and ORTHOVISC(R), manufactured by Anika Therapeutics.

3 Fidia

* Specializes in the HA viscosupplementation market with a five-injection product (HYALGAN(R)) and the first-ever two-injection product (Hymovis(R)) in the U.S.

* TRILURON(R) - A pre-filled HA sodium salt product for knee osteoarthritis treatment.

* The two-injection segment is experiencing rapid growth as lower-injection treatment trends gain traction.

Market Segmentation Summary

  • Bone Graft Substitute Market

* Material Type: Allograft, Demineralized Bone Matrix, Synthetic Substitutes

  • Orthopedic Growth Factor Market

* Indication Type: Cervical Disc Degeneration, Tibial Fracture, Spine, Ankle & Hindfoot Fusions

  • Orthopedic Cell Therapy Market

* Material Type: Platelet-Rich Plasma, Bone Marrow Aspirate Concentrates

  • Hyaluronic Acid (HA) Viscosupplementation Market

* Material Type: Single-Injection, Two-Injection, Three-Injection, Five-Injection Cycles

  • Orthopedic Cartilage Repair Market

* Treatment Type: Osteochondral Allograft, Meniscal Allograft, Autologous Chondrocyte Implantation, Osteochondral Autografts

Global Research Scope

  • Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage

  • Market Size, Market Shares
  • Market Forecasts, Growth Rates
  • Units Sold, Average Selling Prices
  • Procedure Numbers

Qualitative Coverage

  • COVID-19 Impact
  • Market Growth Trends & Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles & Product Portfolios
  • FDA Recalls, Disruptive Technologies
  • Disease Overviews

Data Sources:

  • Primary Interviews with Industry Leaders
  • Government Physician Data & Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

Executive Summary

Global Orthopedic Biomaterials Device Market Overview

Competitive Analysis

Emerging Markets and Technologies

Market Developments

Market Trends

Procedure Segmentation

Market Segmentation

Regions Included

Key Report Updates

Version History

research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

Product Assessment

  • 2.1 Introduction
  • 2.2 Product Portfolios
    • 2.2.1 Bone Graft Substitute
    • 2.2.2 Growth Factors
      • 2.2.2.1 NELL-1 Bone Biologics
      • 2.2.2.2 INFUSE(R) by Medtronic
      • 2.2.2.3 OsteoAMP(R) by Bioventus Surgical
      • 2.2.2.4 OP-1(TM) by Stryker/Olympus Biotech (Delisted)
      • 2.2.2.5 The Osteogrow Study
      • 2.2.2.6 AUGMENT(R) Bone Graft
      • 2.2.2.7 Amplex(R) Osteobiologic Bone Graft Substitute
      • 2.2.2.8 i-Factor(TM) Peptide Bone Matrix
    • 2.2.3 Cell Therapy
      • 2.2.3.1 Platelet-Rich Plasma
      • 2.2.3.2 Bone Marrow Aspirate Concentrate
    • 2.2.4 Hyaluronic Acid Viscosupplementation (HAV)
    • 2.2.5 Cartilage Repair
  • 2.3 Regulatory Issues and Recalls
    • 2.3.1 Bone Graft Substitute Market FDA Recalls
    • 2.3.2 Growth Factor Market FDA Recalls
  • 2.4 Clinical Trials
    • 2.4.1 Bone Graft Substitute Market Clinical Trials
    • 2.4.2 Growth Factor Market Clinical Trials
    • 2.4.3 Cell Therapy Market Clinical Trials
    • 2.4.4 Hyaluronic Acid Viscosupplementation Market
    • 2.4.5 Cartilage Repair Market Clinical Trials

Global Orthopedic Biomaterials Device Market Overview

  • 3.1 Introduction
  • 3.2 Market Overview & Trend Analysis
    • 3.2.1 By Segment
    • 3.2.2 By Region
  • 3.3 Drivers and Limiters
    • 3.3.1 Market Drivers
    • 3.3.2 Market Limiters
  • 3.4 Competitive Market Share Analysis
  • 3.5 Mergers and Acquisitions
  • 3.6 Company Profiles
    • 3.6.1 Arthrex
    • 3.6.2 Biocomposites
    • 3.6.3 Bioventus
    • 3.6.4 DePuy Synthes
    • 3.6.5 Ferring Pharmaceuticals
    • 3.6.6 Fidia Farmaceutici
    • 3.6.7 Isto Biologics
    • 3.6.8 Harvest Technologies (Terumo)
    • 3.6.9 Medtronic
    • 3.6.10 Musculoskeletal Transplant Foundation (MTF)
    • 3.6.11 Orthofix
    • 3.6.12 Sanofi
    • 3.6.13 SeaSpine
    • 3.6.14 Stryker
    • 3.6.15 Vericel
    • 3.6.16 Xtant Medical
    • 3.6.17 Zimmer Biomet
  • 3.7 SWOT Analysis
    • 3.7.1 Arthrex
    • 3.7.2 Biocomposites
    • 3.7.3 Bioventus
    • 3.7.4 DePuy Synthes
    • 3.7.5 Ferring Pharmaceuticals
    • 3.7.6 Fidia Farmaceutici
    • 3.7.7 Harvest Technologies (Terumo)
    • 3.7.8 Medtronic
    • 3.7.9 Musculoskeletal Transplant Foundation (MTF)
    • 3.7.10 Orthofix
    • 3.7.11 Sanofi
    • 3.7.12 SeaSpine
    • 3.7.13 Stryker
    • 3.7.14 Vericel
    • 3.7.15 Xtant Medical (former Surgalign Holdings)
    • 3.7.16 Zimmer Biomet

Orthopedic Bone Graft Substitute Market

  • 4.1 Executive Summary
    • 4.1.1 Global Orthopedic Bone Graft Substitute Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Regions Included
  • 4.2 Introduction
  • 4.3 Procedure Numbers
    • 4.3.1 Total Orthopedic Bone Grafting Procedures
    • 4.3.2 Allograft Procedures
    • 4.3.3 Demineralized Bone Matrix Procedures
    • 4.3.4 Synthetic Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Region
  • 4.5 Market Analysis and Forecast
    • 4.5.1 Total Orthopedic Bone Graft Substitute Market
    • 4.5.2 Allograft Bone Graft Substitute Market
    • 4.5.3 Demineralized Bone Matrix Allograft Bone Graft Substitute Market
    • 4.5.4 Synthetic Bone Graft Substitute Market
      • 4.5.4.1 Synthetic Bone Graft Substitute Market by Generation Type
  • 4.6 Unit Analysis
    • 4.6.1 Allograft Bone Graft Substitute Unit Analysis
      • 4.6.1.1 Allograft Bone Graft Substitute Units Sold by Indication
      • 4.6.1.1.1 Spine Allograft Bone Graft Substitute Units Sold
      • 4.6.1.1.2 Trauma Allograft Bone Graft Substitute Units Sold
      • 4.6.1.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold
    • 4.6.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Unit Analysis
      • 4.6.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication
      • 4.6.2.1.1 Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
      • 4.6.2.1.2 Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
      • 4.6.2.1.3 Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
    • 4.6.3 Synthetic Bone Graft Substitute Unit Analysis
      • 4.6.3.1 Synthetic Bone Graft Substitute Units Sold by Indication
      • 4.6.3.1.1 Spine Synthetic Bone Graft Substitute Units Sold
      • 4.6.3.1.2 Trauma Synthetic Bone Graft Substitute Units Sold
      • 4.6.3.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold
  • 4.7 Drivers and Limiters
    • 4.7.1 Market Drivers
    • 4.7.2 Market Limiters
  • 4.8 Competitive Market Share Analysis

Orthopedic Growth Factor Market

  • 5.1 Executive Summary
    • 5.1.1 Global Orthopedic Growth Factor Market Overview
    • 5.1.2 Competitive Analysis
    • 5.1.3 Regions Included
  • 5.2 Introduction
  • 5.3 Procedure Numbers
  • 5.4 Market Analysis and Forecast
  • 5.5 Unit Analysis
    • 5.5.1 Cervical Disc Degeneration Growth Factor Units Sold
    • 5.5.1 Tibial Fracture Orthopedic Growth Factor Units Sold
    • 5.5.2 Spine Orthopedic Growth Factor Units Sold
    • 5.5.3 Ankle & Hindfoot Fusion Growth Factor Units Sold
  • 5.6 Drivers and Limiters
    • 5.6.1 Market Drivers
    • 5.6.2 Market Limiters
  • 5.7 Competitive Market Share Analysis

Orthopedic Cell Therapy Market

  • 6.1 Executive Summary
    • 6.1.1 Global Orthopedic Cell Therapy Market Overview
    • 6.1.2 Competitive Analysis
    • 6.1.3 Regions Included
  • 6.2 Introduction
    • 6.2.1 Platelet-Rich Plasma
    • 6.2.2 Concentrated Bone Marrow Aspirate
  • 6.3 Procedure Numbers
    • 6.3.1 Total Orthopedic Cell Therapy Procedures
    • 6.3.2 Platelet-Rich Plasma Procedures
    • 6.3.3 Bone Marrow Aspirate Concentrate Procedures
  • 6.4 Market Overview
    • 6.4.1 By Segment
    • 6.4.2 By Region
  • 6.5 Market Analysis and Forecast
    • 6.5.1 Platelet-Rich Plasma Market
    • 6.5.2 Bone Marrow Aspirate Concentrate Market
  • 6.6 Unit Analysis
    • 6.6.1 Platelet-Rich Plasma Unit Analysis
      • 6.6.1.1 Platelet-Rich Plasma Units Sold by Indication
    • 6.6.2 Bone Marrow Aspirate Concentrate Unit Analysis
      • 6.6.2.1 Bone Marrow Aspirate Concentrate Units Sold by Indication
  • 6.7 Drivers and Limiters
    • 6.7.1 Market Drivers
    • 6.7.2 Market Limiters
  • 6.8 Competitive Market Share Analysis

Hyaluronic Acid Viscosupplementation Market

  • 7.1 Executive Summary
    • 7.1.1 Global Hyaluronic Acid Viscosupplementation Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Regions Included
  • 7.2 Introduction
    • 7.2.1 Benefits of Viscosupplementation
    • 7.2.2 Synovial Fluid
    • 7.2.3 Product Types
      • 7.2.3.1 Single-Injection Products
      • 7.2.3.2 Two-Injection Cycle Products
      • 7.2.3.3 Three-Injection Cycle Products
      • 7.2.3.4 Three-/Five-Injection Cycle Products
  • 7.3 Procedure Numbers
  • 7.4 Market Overview
    • 7.4.1 By Segment
    • 7.4.2 By Region
  • 7.5 Market Analysis and Forecast
    • 7.5.1 Total Hyaluronic Acid Viscosupplementation Market
    • 7.5.2 Single-Injection Hyaluronic Acid Viscosupplementation Market
    • 7.5.3 Two-Injection Hyaluronic Acid Viscosupplementation Market
    • 7.5.4 Three-Injection Hyaluronic Acid Viscosupplementation Market
    • 7.5.5 Five-Injection Hyaluronic Acid Viscosupplementation Market
  • 7.6 Drivers and Limiters
    • 7.6.1 Market Drivers
    • 7.6.2 Market Limiters
  • 7.7 Competitive Market Share Analysis

Orthopedic Cartilage Repair Market

  • 8.1 Executive Summary
    • 8.1.1 Global Orthopedic Cartilage Repair Market Overview
    • 8.1.2 Regions Included
  • 8.2 Introduction
    • 8.2.1 Anatomy
    • 8.2.2 Methods for Cartilage Repair
      • 8.2.2.1 Osteochondral Allograft Transfer
      • 8.2.2.2 Autologous Chondrocyte Implantation
      • 8.2.2.3 Meniscal Allograft Transplantation
      • 8.2.2.4 Osteochondral Autograft
      • 8.2.2.5 Microfracture
      • 8.2.2.6 Microfracture Adjunct
      • 8.2.2.7 Osteoarticular Autograft Transfer System
      • 8.2.2.8 Particulated Juvenile Allograft
  • 8.3 Procedure Numbers
    • 8.3.1 Total Orthopedic Cartilage Repair Procedures
    • 8.3.2 Osteochondral Allograft Procedures
    • 8.3.3 Meniscal Allograft Procedures
    • 8.3.4 Autologous Chondrocyte Implantation Procedures
    • 8.3.5 Osteochondral Autograft Procedures
  • 8.4 Market Overview
    • 8.4.1 By Segment
    • 8.4.2 By Region
  • 8.5 Market Analysis and Forecast
    • 8.5.1 Total Orthopedic Cartilage Repair Market
    • 8.5.2 Osteochondral Allograft Market
    • 8.5.3 Meniscal Allograft Market
    • 8.5.4 Autologous Chondrocyte Implantation Market
    • 8.5.5 Osteochondral Autograft Market
  • 8.6 Drivers and Limiters
    • 8.6.1 Market Drivers
    • 8.6.2 Market Limiters
  • 8.7 Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 1-1: Orthopedic Biomaterials Device Market by Segment, Global, 2024 - 2031
  • Chart 1-2: Orthopedic Bone Graft Substitute Procedures, Global, 2024
  • Chart 3-1: Orthopedic Biomaterials Device Market by Segment, Global, 2021 - 2031
  • Chart 3-2: Orthopedic Biomaterials Device Market by Region, Global, 2021 - 2031
  • Chart 3-3: Leading Competitors, Orthopedic Biomaterials Device Market, Global, 2024
  • Chart 4-1: Orthopedic Bone Graft Substitute Market, Global, 2024 & 2031
  • Chart 4-2: Orthopedic Bone Graft Substitute Procedures, Global, 2024
  • Chart 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021- 2031
  • Chart 4-4: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 - 2031
  • Chart 4-5: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 - 2031
  • Chart 4-6: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024
  • Chart 5-1: Orthopedic Growth Factor Market, Global, 2024 & 2031
  • Chart 5-2: Orthopedic Growth Factor Procedures, Global, 2024
  • Chart 5-3: Orthopedic Growth Factor Procedures by Segment, Global, 2021 - 2031
  • Chart 5-4: Orthopedic Growth Factor Device Market, Global, 2021 - 2031
  • Chart 5-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024
  • Chart 6-1: Orthopedic Cell Therapy Market, Global, 2024 & 2031
  • Chart 6-2: Orthopedic Cell Therapy Procedures, Global, 2024
  • Chart 6-3: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Chart 6-4: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031
  • Chart 6-5: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031
  • Chart 6-6: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024
  • Chart 7-1: Hyaluronic Acid Viscosupplementation Market, Global, 2024 & 2031
  • Chart 7-2: Hyaluronic Acid Viscosupplementation Procedures, Global, 2024
  • Chart 7-3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 - 2031
  • Chart 7-4: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 - 2031
  • Chart 7-5: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 - 2031
  • Chart 7-6: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024
  • Chart 8-1: Orthopedic Cartilage Repair Market, Global, 2024 & 2031
  • Chart 8-2: Orthopedic Cartilage Repair Procedures, Global, 2024
  • Chart 8-3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 - 2031
  • Chart 8-4: Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 - 2031
  • Chart 8-5: Orthopedic Cartilage Repair Device Market by Region, Global, 2021 - 2031
  • Chart 8-6: Leading Competitors, Cartilage Repair Market, Global, 2024

LIST OF FIGURES

  • Figure 1-1: Orthopedic Biomaterials Device Market Share Ranking by Segment, Global, 2024
  • Figure 1-2: Companies Researched in This Report (1 of 2)
  • Figure 1-3: Companies Researched in This Report (2 of 2)
  • Figure 1-4: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (1 of 11)
  • Figure 1-5: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (3 of 11)
  • Figure 1-6: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (4 of 11)
  • Figure 1-7: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (5 of 11)
  • Figure 1-8: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (6 of 11)
  • Figure 1-9: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (7 of 11)
  • Figure 1-10: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (8 of 11)
  • Figure 1-11: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (9 of 11)
  • Figure 1-12: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (10 of 11)
  • Figure 1-13: Recent Events in the Orthopedic Biomaterials Device Market, Global, 2022 - 2024 (11 of 11)
  • Figure 1-14: Factors Impacting the Orthopedic Biomaterials Device Market by Segment, Global
  • Figure 1-15: Orthopedic Biomaterial Procedure Segmentation
  • Figure 1-16: Orthopedic Biomaterial Regions Covered, Global (1 of 2)
  • Figure 1-17: Orthopedic Biomaterial Regions Covered, Global (2 of 2)
  • Figure 1-18: Key Report Updates
  • Figure 1-19: Version History
  • Figure 2-1: Bone Graft Substitute Products by Company (1 of 4)
  • Figure 2-2: Bone Graft Substitute Products by Company (2 of 4)
  • Figure 2-3: Bone Graft Substitute Products by Company (3 of 4)
  • Figure 2-4: Bone Graft Substitute Products by Company (4 of 4)
  • Figure 2-5: Growth Factor Products by Company
  • Figure 2-6: Cell Therapy Products by Company
  • Figure 2-7: Hyaluronic Acid Viscosupplementation by Products by Company
  • Figure 2-8: Cartilage Repair Products by Company
  • Figure 2-9: Class 2 Device Recall GRAFTON DBM (Gel, Flex, Putty, Matrix, Crunch)
  • Figure 2-10: Class 2 Device Recall GRAFTON PLUS DBM Paste
  • Figure 2-11: Class 2 Device Recall Magnifuse Bone Graft
  • Figure 2-12: Class 2 Device Recall Grafton DBF Inject
  • Figure 2-13: Class 2 Device Recall OsteoSelect Demineralized Bone Matrix (DBM) Putty
  • Figure 2-14: Class 2 Device Recall PROSTIM 10cc INJECTABLE
  • Figure 2-15: Class 2 Device Recall Opteform Allograft Disc
  • Figure 2-16: Class 2 Device Recall Bioactive Bone Graft Putty
  • Figure 2-17: Class 3 Device Recall iFACTOR Peptide Enhanced Bone Graft Putty
  • Figure 2-18: ACDF Using Structural Allograft vs. Tritanium C
  • Figure 2-19: Clinical Study of Bone Graft Substitutes in Orthopaedic and Spinal Applications
  • Figure 2-20: OSTEOAMP Lumbar Fusion Intra-Patient Controlled Study
  • Figure 2-21: Rate of Bony Fusion Using NanoBone(R) Synthetic Bone Graft Versus Local Autologous Bone Graft. (BONE)
  • Figure 2-22: Demineralized Bone Matrix Rotator Cuff Study
  • Figure 2-23: Clinical Outcomes Associated with the Use of ViviGen(R) for the Treatment of Lumbar Degenerative Disc Disease
  • Figure 2-24: The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction
  • Figure 2-25: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
  • Figure 2-26: Transforaminal Lumbar Interbody Fusion (TLIF)
  • Figure 2-27: A Post Market Surveillance on INFUSE Bone Graft
  • Figure 2-28: Long-term Safety and Effectiveness of AUGMENT(R) Injectable Bone Graft Compared to Autologous Bone Graft
  • Figure 2-29: Evaluation of the Effectiveness of AMPLEX(R) Compared to Autogenous Bone Grafts
  • Figure 2-30: Effect of PRP, PPP, & BMAC on Functional Outcomes Following Hip Arthroscopy for Acetabular Labral Pathologies
  • Figure 2-31: Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
  • Figure 2-32: BMAC & Allograft vs BMP-2
  • Figure 2-33: Bone Marrow Aspirate Concentrate (BMAC)Treatment for Knee Osteoarthritis (BMAC)
  • Figure 2-34: Platelet Rich Plasma in Knee Osteoarthritis
  • Figure 2-35: Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
  • Figure 2-36: A Prospective Study of Clinical Outcomes Following a Single Intradiscal Injection of Bone Marrow Aspirate Concentrate (BMAC) for Single Level Discogenic Low Back Pain
  • Figure 2-37: ArtiAid(R) for Knee Osteoarthritis: A Post-market Study
  • Figure 2-38: The Effectiveness of Different Doses of Hyaluronic Acid Injections in Knee Osteoarthritis
  • Figure 2-39: Euflexxa for the Treatment of Osteoarthritis
  • Figure 2-40: MONOVISC for Ankle Joint Pain Relief
  • Figure 2-41: MONOVISC for Shoulder Joint Pain Relief
  • Figure 2-42: MONOVISC for Hip Joint Pain Relief
  • Figure 2-43: Comparison of Hyaluronic Acid and Platelet-Rich Plasma Injections
  • Figure 2-44: Prospective Evaluation of ProChondrix CR for Repair of Articular Cartilage Defects on Femoral Condyle and Patella
  • Figure 2-45: Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
  • Figure 2-46: Phase 2 Clinical Trial of CartiLife(R) in the United States
  • Figure 2-47: A Study to Evaluate the Efficacy of BioCartilage(R) Micronized Cartilage Matrix in Microfracture Treatment of Osteochondral Defects
  • Figure 3-1: Orthopedic Biomaterials Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 3-2: Orthopedic Biomaterials Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 3-3: Leading Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2024
  • Figure 3-4: Other Notable Competitors, Orthopedic Biomaterials Device Market by Segment, Global, 2024
  • Figure 3-5: SWOT Analysis, Arthrex
  • Figure 3-6: SWOT Analysis, Biocomposites
  • Figure 3-7: SWOT Analysis, Bioventus
  • Figure 3-8: SWOT Analysis, DePuy Synthes
  • Figure 3-9: SWOT Analysis, Ferring Pharmaceuticals
  • Figure 3-10: SWOT Analysis, Fidia Farmaceutici
  • Figure 3-11: SWOT Analysis, Harvest Technologies
  • Figure 3-12: SWOT Analysis, Medtronic
  • Figure 3-13: SWOT Analysis, MTF
  • Figure 3-14: SWOT Analysis, Orthofix
  • Figure 3-15: SWOT Analysis, Sanofi
  • Figure 3-16: SWOT Analysis, Sanofi
  • Figure 3-17: SWOT Analysis, Stryker
  • Figure 3-18: SWOT Analysis, Vericel Corporation
  • Figure 3-19: SWOT Analysis, Surgalign Holdings
  • Figure 3-20: SWOT Analysis, Zimmer Biomet
  • Figure 4-1: Orthopedic Bone Graft Substitute Regions Covered, Global (1 of 2)
  • Figure 4-2: Orthopedic Bone Graft Substitute Regions Covered, Global (2 of 2)
  • Figure 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021 - 2031
  • Figure 4-4: Orthopedic Bone Grafting Procedures by Region, Global, 2021 - 2031
  • Figure 4-5: Orthopedic Bone Grafting Procedures by Country, North America, 2021 - 2031
  • Figure 4-6: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 4-7: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 4-8: Orthopedic Bone Grafting Procedures by Country, Western Europe, 2021- 2031
  • Figure 4-9: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-10: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-11: Orthopedic Bone Grafting Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-12: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021- 2031 (1 of 3)
  • Figure 4-13: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-14: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-15: Orthopedic Bone Grafting Procedures by Country, Africa, 2021 - 2031
  • Figure 4-16: Allograft Procedures by Region, Global, 2021- 2031
  • Figure 4-17: Allograft Procedures by Country, North America, 2021- 2031
  • Figure 4-18: Allograft Procedures by Country, Latin America, 2021- 2031 (1 of 2)
  • Figure 4-19: Allograft Procedures by Country, Latin America, 2021- 2031 (2 of 2)
  • Figure 4-20: Allograft Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-21: Allograft Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-22: Allograft Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-23: Allograft Procedures by Country, Middle East, 2021- 2031
  • Figure 4-24: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 4-25: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-26: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-27: Allograft Procedures by Country, Africa, 2021- 2031
  • Figure 4-28: Demineralized Bone Matrix Procedures by Region, Global, 2021- 2031
  • Figure 4-29: Demineralized Bone Matrix Procedures by Country, North America, 2021- 2031
  • Figure 4-30: Demineralized Bone Matrix Procedures by Country, Latin America, 2021- 2031 (1 of 2)
  • Figure 4-31: Demineralized Bone Matrix Procedures by Country, Latin America, 2021- 2031 (2 of 2)
  • Figure 4-32: Demineralized Bone Matrix Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-33: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-34: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-35: Demineralized Bone Matrix Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-36: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021- 2031 (1 of 3)
  • Figure 4-37: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021- 2031 (2 of 3)
  • Figure 4-38: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-39: Demineralized Bone Matrix Procedures by Country, Africa, 2021 - 2031
  • Figure 4-40: Synthetic Procedures by Region, Global, 2021 - 2031
  • Figure 4-41: Synthetic Procedures by Country, North America, 2021 - 2031
  • Figure 4-42: Synthetic Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 4-43: Synthetic Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 4-44: Synthetic Procedures by Country, Western Europe, 2021- 2031
  • Figure 4-45: Synthetic Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-46: Synthetic Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-47: Synthetic Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-48: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 4-49: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-50: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-51: Synthetic Procedures by Country, Africa, 2021 - 2031
  • Figure 4-52: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 4-53: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 4-54: Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-55: Units Sold by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-56: Average Selling Price by Region, Orthopedic Bone Graft Substitute Market, Global, 2021- 2031 (US$)
  • Figure 4-57: Market Value by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-58: Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-59: Units Sold by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-60: Average Selling Price by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-61: Market Value by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-62: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-63: Units Sold by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-64: Average Selling Price by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-65: Market Value by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-66: Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-67: Units Sold by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-68: Average Selling Price by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-69: Market Value by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-70: Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-71: Units Sold by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-72: Average Selling Price by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-73: Market Value by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-74: Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-75: Units Sold by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-76: Average Selling Price by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-77: Market Value by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-78: Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-79: Spine Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-80: Trauma Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-81: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, Global, 2021- 2031
  • Figure 4-82: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-83: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-84: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-85: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-86: Synthetic Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-87: Spine Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-88: Trauma Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-89: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-90: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024
  • Figure 5-1: Orthopedic Growth Factor Regions Covered, Global (1 of 2)
  • Figure 5-2: Orthopedic Growth Factor Regions Covered, Global (2 of 2)
  • Figure 5-3: Orthopedic Growth Factor Procedures by Region, Global, 2024 - 2031
  • Figure 5-4: Orthopedic Growth Factor Procedures by Country, North America, 2021 - 2031
  • Figure 5-5: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 5-6: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 5-7: Orthopedic Growth Factor Procedures by Country, Western Europe, 2021 - 2031
  • Figure 5-8: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 5-9: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 5-10: Orthopedic Growth Factor Procedures by Country, Middle East, 2021 - 2031
  • Figure 5-11: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 5-12: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 5-13: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 5-14: Orthopedic Growth Factor Procedures by Country, Africa, 2021 - 2031
  • Figure 5-15: Orthopedic Growth Factor Market, Global, 2021 - 2031
  • Figure 5-16: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031
  • Figure 5-17: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$)
  • Figure 5-18: Market Value by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$M)
  • Figure 5-19: Cervical Disc Degeneration Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-20: Tibial Fracture Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-21: Spine Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-22: Ankle & Hindfoot Fusion Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-23: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024
  • Figure 6-1: Orthopedic Cell Therapy Regions Covered, Global (1 of 2)
  • Figure 6-2: Orthopedic Cell Therapy Regions Covered, Global (2 of 2)
  • Figure 6-3: Orthopedic Cell Therapy Procedures by Segment, Global, 2021 - 2031
  • Figure 6-4: Orthopedic Cell Therapy Procedures by Region, Global, 2021 - 2031
  • Figure 6-5: Orthopedic Cell Therapy Procedures by Country, North America, 2021- 2031
  • Figure 6-6: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6-7: Orthopedic Cell Therapy Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6-8: Orthopedic Cell Therapy Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6-9: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6-10: Orthopedic Cell Therapy Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6-11: Orthopedic Cell Therapy Procedures by Country, Middle East, 2021 - 2031
  • Figure 6-12: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6-13: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6-14: Orthopedic Cell Therapy Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6-15: Orthopedic Cell Therapy Procedures by Country, Africa, 2021 - 2031
  • Figure 6-16: Orthopedic Platelet-Rich-Plasma Procedures by Region, Global, 2021 - 2031
  • Figure 6-17: Orthopedic Platelet-Rich-Plasma Procedures by Country, North America, 2021 - 2031
  • Figure 6-18: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6-19: Orthopedic Platelet-Rich-Plasma Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6-20: Orthopedic Platelet-Rich-Plasma Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6-21: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6-22: Orthopedic Platelet-Rich-Plasma Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6-23: Orthopedic Platelet-Rich-Plasma Procedures by Country, Middle East, 2021 - 2031
  • Figure 6-24: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6-25: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6-26: Orthopedic Platelet-Rich-Plasma Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6-27: Orthopedic Platelet-Rich-Plasma Procedures by Country, Africa, 2021 - 2031
  • Figure 6-28: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Region, Global, 2021 - 2031
  • Figure 6-29: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, North America, 2021 - 2031
  • Figure 6-30: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 6-31: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 6-32: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Western Europe, 2021 - 2031
  • Figure 6-33: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 6-34: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 6-35: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Middle East, 2021 - 2031
  • Figure 6-36: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 6-37: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 6-38: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 6-39: Orthopedic Bone Marrow Aspirate Concentrate Procedures by Country, Africa, 2021 - 2031
  • Figure 6-40: Orthopedic Cell Therapy Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 6-41: Orthopedic Cell Therapy Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 6-42: Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6-43: Units Sold by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031
  • Figure 6-44: Average Selling Price by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$)
  • Figure 6-45: Market Value by Region, Platelet-Rich Plasma Market, Global, 2021 - 2031 (US$M)
  • Figure 6-46: Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6-47: Units Sold by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031
  • Figure 6-48: Average Selling Price by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$)
  • Figure 6-49: Market Value by Region, Bone Marrow Aspirate Concentrate Market, Global, 2021 - 2031 (US$M)
  • Figure 6-50: Platelet-Rich Plasma Units Sold by Indication, Global, 2021 - 2031
  • Figure 6-51: Bone Marrow Aspirate Concentrate Units Sold by Indication, Global, 2021 - 2031
  • Figure 6-52: Leading Competitors, Orthopedic Cell Therapy Market, Global, 2024
  • Figure 7-1: Hyaluronic Acid Viscosupplementation Regions Covered, Global (1 of 2)
  • Figure 7-2: Hyaluronic Acid Viscosupplementation Regions Covered, Global (2 of 2)
  • Figure 7-3: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Region, Global, 2021 - 2031
  • Figure 7-4: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, North America, 2021 - 2031
  • Figure 7-5: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 7-6: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 7-7: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Western Europe, 2021 - 2031
  • Figure 7-8: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 7-9: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 7-10: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Middle East, 2021 - 2031
  • Figure 7-11: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 7-12: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 7-13: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 7-14: Orthopedic Hyaluronic Acid Viscosupplementation Procedures by Country, Africa, 2021 - 2031
  • Figure 7-15: Hyaluronic Acid Viscosupplementation Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 7-16: Hyaluronic Acid Viscosupplementation Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 7-17: Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-18: Units Sold by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-19: Average Selling Price by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
  • Figure 7-20: Market Value by Region, Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
  • Figure 7-21: Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-22: Units Sold by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-23: Average Selling Price by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
  • Figure 7-24: Market Value by Region, Single-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
  • Figure 7-25: Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-26: Units Sold by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-27: Average Selling Price by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
  • Figure 7-28: Market Value by Region, Two-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
  • Figure 7-29: Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-30: Units Sold by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-31: Average Selling Price by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$)
  • Figure 7-32: Market Value by Region, Three-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
  • Figure 7-33: Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-34: Units Sold by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031
  • Figure 7-35: Average Selling Price by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021- 2031 (US$)
  • Figure 7-36: Market Value by Region, Five-Injection Hyaluronic Acid Viscosupplementation Market, Global, 2021 - 2031 (US$M)
  • Figure 7-37: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Global, 2024
  • Figure 8-1: Orthopedic Cartilage Repair Regions Covered, Global (1 of 2)
  • Figure 8-2: Orthopedic Cartilage Repair Regions Covered, Global (2 of 2)
  • Figure 8-3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 - 2031
  • Figure 8-4: Orthopedic Cartilage Repair Procedures by Region, Global, 2021 - 2031
  • Figure 8-5: Osteochondral Allograft Procedures by Region, Global, 2021 - 2031
  • Figure 8-6: Meniscal Allograft Procedures by Region, Global, 2021 - 2031
  • Figure 8-7: Autologous Chondrocyte Implantation Procedures by Region, Global, 2021 - 2031
  • Figure 8-8: Osteochondral Autograft Procedures by Region, Global, 2021 - 2031
  • Figure 8-9: Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 8-10: Orthopedic Cartilage Repair Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 8-11: Orthopedic Cartilage Repair Market, Global, 2021 - 2031
  • Figure 8-12: Units Sold by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031
  • Figure 8-13: Average Selling Price by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031 (US$)
  • Figure 8-14: Market Value by Region, Orthopedic Cartilage Repair Market, Global, 2021 - 2031 (US$M)
  • Figure 8-15: Osteochondral Allograft Market, Global, 2021 - 2031
  • Figure 8-16: Units Sold by Region, Osteochondral Allograft Market, Global, 2021 - 2031
  • Figure 8-17: Average Selling Price by Region, Osteochondral Allograft Market, Global, 2021 - 2031 (US$)
  • Figure 8-18: Market Value by Region, Osteochondral Allograft Market, Global, 2021 - 2031 (US$M)
  • Figure 8-19: Meniscal Allograft Market, Global, 2021 - 2031
  • Figure 8-20: Units Sold by Region, Meniscal Allograft Market, Global, 2021 - 2031
  • Figure 8-21: Average Selling Price by Region, Meniscal Allograft Market, Global, 2021 - 2031 (US$)
  • Figure 8-22: Market Value by Region, Meniscal Allograft Market, Global, 2021 - 2031 (US$M)
  • Figure 8-23: Autologous Chondrocyte Implantation Market, Global, 2021- 2031
  • Figure 8-24: Units Sold by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031
  • Figure 8-25: Average Selling Price by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031 (US$)
  • Figure 8-26: Market Value by Region, Autologous Chondrocyte Implantation Market, Global, 2021 - 2031 (US$M)
  • Figure 8-27: Osteochondral Autograft Market, Global, 2021 - 2031
  • Figure 8-28: Units Sold by Region, Osteochondral Autograft Market, Global, 2021 - 2031
  • Figure 8-29: Average Selling Price by Region, Osteochondral Autograft Market, Global, 2021 - 2031 (US$)
  • Figure 8-30: Market Value by Region, Osteochondral Autograft Market, Global, 2021 - 2031 (US$M)
  • Figure 8-31: Leading Competitors, Cartilage Repair Market, Global, 2024